Srinivas Rao - Jan 7, 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Co-Founder and Chief Executive Officer
Signature
/s/ Ryan Barrett , Attorney-in-fact
Stock symbol
ATAI
Transactions as of
Jan 7, 2025
Transactions value $
$0
Form type
4
Date filed
1/10/2025, 04:15 PM
Previous filing
Oct 4, 2024
Next filing
Mar 19, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +2.34M $0.00 2.34M Jan 7, 2025 Common Shares 2.34M $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest as to 25% on January 1, 2026, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.

Remarks:

Co-Founder and Chief Executive Officer